British Society of Gastroenterology guidelines on colorectal surveillance in inflammatory bowel disease

East, James Edward, Gordon, Morris, Nigam, Gaurav Bhaskar, Sinopoulou, Vassiliki, Bateman, Adrian C., Din, Shahida, Iacucci, Marietta, Kabir, Misha, Lamb, Christopher Andrew, Wilson, Ana, Al Bakir, Ibrahim, Dhar, Anjan, Dolwani, Sunil ORCID: https://orcid.org/0000-0002-3113-5472, Faiz, Omar, Hart, Ailsa, Hayee, Bu'Hussain, Healey, Chris, Leedham, Simon John, Novelli, Marco R., Raine, Tim, Rutter, Matthew D., Shepherd, Neil A., Subramanian, Venkataraman, Vance, Margaret, Wakeman, Ruth, White, Lydia, Trudgill, Nigel J. and Morris, A. John 2025. British Society of Gastroenterology guidelines on colorectal surveillance in inflammatory bowel disease. Gut 10.1136/gutjnl-2025-335023

PDF - Published Version Available under License Creative Commons Attribution Non-commercial. Download (5MB)

Abstract

Patients with inflammatory bowel disease (IBD) remain at increased risk for colorectal cancer and death from colorectal cancer compared with the general population despite improvements in inflammation control with advanced therapies, colonoscopic surveillance and reductions in environmental risk factors. This guideline update from 2010 for colorectal surveillance of patients over 16 years with colonic inflammatory bowel disease was developed by stakeholders representing UK physicians, endoscopists, surgeons, specialist nurses and patients with GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodological support.An a priori protocol was published describing the approach to three levels of statement: GRADE recommendations, good practice statements or expert opinion statements. A systematic review of 7599 publications, with appraisal and GRADE analysis of trials and network meta-analysis, where appropriate, was performed. Risk thresholding guided GRADE judgements.We made 73 statements for the delivery of an IBD colorectal surveillance service, including outcome standards for service and endoscopist audit, and the importance of shared decision-making with patients.Core areas include: risk of colorectal cancer, IBD-related post-colonoscopy colorectal cancer; service organisation and supporting patient concordance; starting and stopping surveillance, who should or should not receive surveillance; risk stratification, including web-based multivariate risk calculation of surveillance intervals; colonoscopic modalities, bowel preparation, biomarkers and artificial intelligence aided detection; chemoprevention; the role of non-conventional dysplasia, serrated lesions and non-targeted biopsies; management of dysplasia, both endoscopic and surgical, and the structure and role of the multidisciplinary team in IBD dysplasia management; training in IBD colonoscopic surveillance, sustainability (green endoscopy), cost-effectiveness and patient experience. Sixteen research priorities are suggested. [Abstract copyright: © Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.]

Item Type:	Article
Date Type:	Published Online
Schools:	Schools > Medicine
Publisher:	BMJ Publishing Group
ISSN:	0017-5749
Date of First Compliant Deposit:	3 June 2025
Date of Acceptance:	12 March 2025
Last Modified:	03 Jun 2025 10:15
URI:	https://orca.cardiff.ac.uk/id/eprint/178698

Actions (repository staff only)

Edit Item